MYADMIA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MYADMIA Trademark

Serial Number: 97587826 • Registration: 7484496

MYADMIA is a trademark filed by Takeda Pharmaceuticals International AG on September 12, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Takeda Pharmaceuticals International AG (58 trademarks)

Glattpark-Opfikon 8152 , CH

Entity Type: 99

Trademark Details

Filing Date

September 12, 2022

Registration Date

August 27, 2024

Published for Opposition

June 11, 2024

Goods & Services

Pharmaceutical preparations, namely, preparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 1, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2024 CRFA
ASSIGNED TO LIE
Mar 27, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 14, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 14, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 NWOS
NEW APPLICATION ENTERED
Sep 15, 2022 NWAP